Unknown

Dataset Information

0

Impairing Powerhouse in Colon Cancer Cells by Hydrazide-Hydrazone-Based Small Molecule.


ABSTRACT: Mitochondrion has emerged as one of the unconventional targets in next-generation cancer therapy. Hence, small molecules targeting mitochondria in cancer cells have immense potential in the next-generation anticancer therapeutics. In this report, we have synthesized a library of hydrazide-hydrazone-based small molecules and identified a novel compound that induces mitochondrial outer membrane permeabilization by inhibiting antiapoptotic B-cell CLL/lymphoma 2 (Bcl-2) family proteins followed by sequestration of proapoptotic cytochrome c. The new small molecule triggered programmed cell death (early and late apoptosis) through cell cycle arrest in the G2/M phase and caspase-9/3 cleavage in HCT-116 colon cancer cells, confirmed by an array of fluorescence confocal microscopy, cell sorting, and immunoblotting analysis. Furthermore, cell viability studies have verified that the small molecule rendered toxicity to a panel of colon cancer cells (HCT-116, DLD-1, and SW-620), keeping healthy L929 fibroblast cells unharmed. The novel small molecule has the potential to form a new understudied class of mitochondria targeting anticancer agent.

SUBMITTER: Patil S 

PROVIDER: S-EPMC6044916 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Impairing Powerhouse in Colon Cancer Cells by Hydrazide-Hydrazone-Based Small Molecule.

Patil Sohan S   Kuman Meenu Mahesh MM   Palvai Sandeep S   Sengupta Poulomi P   Basu Sudipta S  

ACS omega 20180202 2


Mitochondrion has emerged as one of the unconventional targets in next-generation cancer therapy. Hence, small molecules targeting mitochondria in cancer cells have immense potential in the next-generation anticancer therapeutics. In this report, we have synthesized a library of hydrazide-hydrazone-based small molecules and identified a novel compound that induces mitochondrial outer membrane permeabilization by inhibiting antiapoptotic B-cell CLL/lymphoma 2 (Bcl-2) family proteins followed by s  ...[more]

Similar Datasets

| S-EPMC4988495 | biostudies-literature
| S-EPMC11348242 | biostudies-literature
| S-EPMC10378024 | biostudies-literature
| S-EPMC9764074 | biostudies-literature
| S-EPMC5681330 | biostudies-literature
| S-EPMC5453412 | biostudies-literature
| S-EPMC4914331 | biostudies-literature
| S-EPMC2955773 | biostudies-literature
| S-EPMC8487726 | biostudies-literature
| S-EPMC7435865 | biostudies-literature